Factor VIII Inhibitor Bypassing Activity

1 Drug classified under this drug class

Factor VIII Inhibitor Bypassing Activity. Factor VIII Inhibitor Bypassing Activity 500, 1000 U/vial.
VIAL: (powd. for sol. for inj.): 500 U, 1,000
U. General dose of 50 to 100 U/kg bdy wt
is recommend., but a single dose of
100 U/kg bdy wt and max. dly dose of
200 U/kg bdy wt must not be exceed.
unless otherwise justified. Dosage
must be individ. adjust. accord. to
locat. and extent of the bleed., and pts.
med. cond. See lit.
Control of bleed. episodes in haemophilia
A pts. with Factor VIII Inhib. and also in pts
with acquired Factor VIII Inhib. Control of
bleed. in hemophilia B pts with inhib., if no
other specific tmt is available.
C/I: (If therap. alternatives are available):
Hypersens. to the product; Dissemin.
Intrav. Coag. (DIC); Acute thromb./
embol. (incl. MI).